Zobrazeno 1 - 10
of 39
pro vyhledávání: '"I. P. Stolyarov"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 1S, Pp 69-72 (2021)
The spread of the COVID-19 pandemic posed a serious challenge for scientific and clinical medical institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss the associations between coronavirus infection a
Externí odkaz:
https://doaj.org/article/78b8f72421e6448cb22c463ba91d3747
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 4, Pp 125-129 (2019)
Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS (SPMS). To date, there has not been a sufficiently effective therapy for SPMS. Siponimod is a selective sphingosine-1-phosphate types 1 and 5 receptor m
Externí odkaz:
https://doaj.org/article/8c613ea51d0f41bba89ae1661e68182a
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 6, Iss 2, Pp 32-37 (2017)
In this article, universal guidelines and requirements to clinicaltrials of new drugs in multiple sclerosis are presented.Principles of patients informed consent, various ethicalaspects and possible problems occurring in the course of clinicaltrials
Externí odkaz:
https://doaj.org/article/4e8702edb0df46d6b71fd716b51d42ae
Autor:
A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 7, Iss 1, Pp 27-32 (2015)
Objective: to estimate the time course of changes in foot biomechanical function as multiple sclerosis (MS) progresses in patients with different degrees of disability compared to a control group. Patients and methods. To estimate the time course of
Externí odkaz:
https://doaj.org/article/d69ecc5ae93348e2a2dc0f8bc9f8eb73
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 7, Iss 1, Pp 75-79 (2015)
The paper generalizes the experience with one of the main original drugs for the treatment of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers. The performed analysis of clinical trials suggests the hi
Externí odkaz:
https://doaj.org/article/c8d2d016efc0405493fa26a493c1bd54
Autor:
L. N. Prakhova, Ye. P. Magonov, A. G. Ilves, A. A. Bogdan, G. V. Kataeva, Ye. S. Malakhova, Zh. I. Savintseva, I. D. Stolyarov, T. N. Trofimova
Publikováno v:
Бюллетень сибирской медицины, Vol 12, Iss 3, Pp 52-60 (2013)
The aim of the study was to determine the relationship of global and regional cerebral atrophy and volume of demyelination lesions in the brain with a clinical picture in patients with multiple sclerosis (MS). The study involved 55 patients with MS.
Externí odkaz:
https://doaj.org/article/c4b05e33610c41c88de866a6ffe0fff2
Publikováno v:
Vestnik Roszdravnadzora. 2019:63-69
The article introduces ethical, clinical and scientific aspects of a medicinal drugs research, as well as particularities of conducting of clinical researches on a multiple sclerosis. The article presents major regulatory document on conduction of cl
Autor:
Viktor N. Khrustalev, I. P. Stolyarov, A. B. Ilyukhin, A. V. Churakov, Zh. V. Dobrokhotova, N. S. Smirnova, Ya. V. Zubavichus, Pavel V. Dorovatovskii, A. A. Markov, Ilya A. Yakushev, M. N. Vargaftik, Natalia V. Cherkashina, E. V. Khramov
Publikováno v:
Russian Journal of Coordination Chemistry. 45:253-265
The reaction of platinum acetate blue, empirically described as Pt(OOCMe)2.50, with palladium(II) acetate Pd3(μ-OOCMe)6 gave the first heterometallic acetate-bridged platinum(II) and palladium(II) complex Pd2Pt(μ-OOCMe)6 (I) as co-crystallizates 17
Autor:
Alexander V. Chernyak, Natalia V. Cherkashina, Vyacheslav M. Martynenko, Alexander V. Naumkin, A. V. Churakov, A. B. Kornev, I. P. Stolyarov
Publikováno v:
Russian Journal of Inorganic Chemistry. 64:49-55
New Pt(IV) perfluorocarboxylate complexes of the composition [Pt(RFCOO)4]n and M2[Pt(RFCOO)6] (RF = CF3, C2F5; M = Li, Na, K, Rb, Cs, NMe4) have been synthesized and studied. These complexes are strong oxidizing agents capable of oxidizing alkanes in
Autor:
Vitali A. Grinberg, Natalia A. Mayorova, Andrey A. Shiryaev, Maximillian S. Nickolsky, Alexandr D. Modestov, S. S. Shapovalov, I. P. Stolyarov
Publikováno v:
Materials Chemistry and Physics. 259:123968
A nanoscale bimetallic alloy catalyst PtFe/C is prepared by pyrolysis of the heterometallic platinum-iron carboxylate complex [PtFe(OAc)4]2O⋅4CH2Cl2 on Vulcan XC-72 carbon black. It is characterized by X-ray powder diffraction analysis, X-ray fluor